tert-Butyl 4-(4-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)piperazin-1-yl)piperidine-1-carboxylate
- CAS2241315-05-7
- CatalogueRS-Z401FIW
- FormulaC27H37N5O5
- MW511.28
On this page
Product identification
| Product name | tert-Butyl 4-(4-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)piperazin-1-yl)piperidine-1-carboxylate |
|---|---|
| Catalogue No. | RS-Z401FIW |
| CAS No. | 2241315-05-7 |
| Molecular formula | C27H37N5O5 |
| Molecular weight | 511.28 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | General Reference Standards |
| Drug substance | Lenalidomide |
| Also known as | Pharmaffiliates |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z401FIW / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Lenalidomide
- General Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z401FIW
- Request a quotation for RS-Z401FIW
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Lenalidomide
All 142 further standards are listed here — every link is in the page, not loaded later.
-
Lenalidomide
IN STOCKRS-I017011 -
(R)-3-aminopiperidine-2,6-dione
IN STOCKRS-Z401K6D -
(S)-3-Amino-piperidine-2,6-dione hydrochloride
IN STOCKRS-I011406 -
(S)-3-aminopiperidine-2,6-dione
IN STOCKRS-Z401HGM -
(S)-5-Amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid
IN STOCKRS-Z412T1A -
(S)-5-Amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid
IN STOCKRS-I011143 -
(S)-Benzyl 2,6-dioxopiperidin-3-ylcarbamate
IN STOCKRS-U009161 -
2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-4-carboxylic Acid
IN STOCKRS-P006874 -
2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carboxylic Acid
IN STOCKRS-P006869 -
2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-indene-1,4,7-trione
IN STOCKRS-L027127 -
2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindole-5-carboxylic acid
IN STOCKRS-U211O80 -
2-(Bromomethyl)-3-nitrobenzoic acid
IN STOCKRS-U055210 -
2-amino-N-(2,6-dioxopiperidin-3-yl)-6-methylbenzamide
IN STOCKRS-D003022 -
2-Methyl-3,5-dinitro-benzoic acid methyl ester
IN STOCKRS-U053211 -
2-Methyl-3-nitrobenzoic acid
IN STOCKRS-C001042 -
2-Methyl-4-nitrobenzoic acid
IN STOCKRS-C001043 -
2-methyl-5-nitro-benzoic acid methyl ester
IN STOCKRS-U010419 -
3,5-Dimethyl-1H-pyrrole-2-carboxylic Acid
IN STOCKRS-U211OHU -
3-(2-Chloropyrimidin-4-yl)-1H-indole
IN STOCKRS-P001A0S -
3-(4-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IN STOCKRS-U067015 -
3-(5-Bromo-1-oxo-2-isoindolinyl)piperidine-2,6-dione
IN STOCKRS-P1085014 -
3-(5-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione (BSC)
IN STOCKRS-U067115 -
3-(5-Methyl-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IN STOCKRS-Z398S3I -
3-(6-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IN STOCKRS-P003987 -
3-(7-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IN STOCKRS-P003984 -
3-Amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)propanamide
CUSTOM SYNTHESISRS-D123044 -
3-Aminopiperidine-2,6-dione Hydrochloride
IN STOCKRS-L027010 -
3-Bromoindole-2-carboxylic Acid
CUSTOM SYNTHESISRS-Z401H6C -
3-ethyl-4-methyl-1H-pyrazole-5-carboxylic acid
CUSTOM SYNTHESISRS-U211OYT -
3-Methyl-1H-indole-2-carboxylic Acid
IN STOCKRS-U211NXY -
3-methyl-2-nitro benzoic acid methyl ester
IN STOCKRS-U010355 -
4-Amino-1-isoindolinone
CUSTOM SYNTHESISRS-P152344 -
4-Nitro Lenalidomide
IN STOCKRS-L027016 -
4-Nitrophthalide
IN STOCKRS-L027014 -
5-Amino-5-oxopentanoic acid
IN STOCKRS-P152137 -
5-Bromo-2-bromomethyl-3-nitro-benzoic acid methyl ester
IN STOCKRS-U211MF4 -
5-Fluoro-3-methyl-1H-indole-2-carboxylic Acid
IN STOCKRS-U211O3V -
5-Nitroisobenzofuran-1(3H)-one
IN STOCKRS-P025438 -
7-amino Lenalidomide
CUSTOM SYNTHESISRS-L027026 -
7-Bromo-1H-indole-2-carboxylic Acid
IN STOCKRS-Z401CWN -
Di-tert-butyl dicarbonate
IN STOCKRS-C002168 -
Dimethyl 2-(4-nitro-1-oxoisoindolin-2-yl)pentanedioate
IN STOCKRS-P006A00 -
ethyl 5-amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoate
IN STOCKRS-L027122 -
Hydroxy Lenalidomide
IN STOCKRS-I007011 -
Indole-2-acetic acid
CUSTOM SYNTHESISRS-P031124 -
L-Glutamic Anhydride Hydrochloride
CUSTOM SYNTHESISRS-L027034 -
L-Glutamic Anhydride Hydrochloride
IN STOCKRS-Z412R38 -
L-Glutamine tert-Butyl Ester Hydrochloride
IN STOCKRS-U017877 -
Lenalidomide 13C5
IN STOCKRS-L027052 -
Lenalidomide 3,4,4,5,5-d5
IN STOCKRS-L027045 -
Lenalidomide Dimethyl sulphoxide
IN STOCKRS-L027047 -
Lenalidomide Form-B
IN STOCKRS-L027039 -
Lenalidomide Impurity NS
IN STOCKRS-L027013 -
Lenalidomide N-Formyl Impurity
IN STOCKRS-L027027 -
Lenalidomide N-Hydroxy Impurity
IN STOCKRS-L027032 -
Lenalidomide-acetylene-Br
IN STOCKRS-L027057 -
Lenalidomide-C3-OH
BACK ORDERRS-L027059 -
Lenalidomide-C4-acid
BACK ORDERRS-L027061 -
Lenalidomide-C4-NH2
CUSTOM SYNTHESISRS-Z004YND -
Lenalidomide-C4-NH2 (hydrochloride)
BACK ORDERRS-L027060 -
Lenalidomide-C5-acid
BACK ORDERRS-L027063 -
Lenalidomide-C5-NH2 (hydrochloride)
BACK ORDERRS-L027062 -
Lenalidomide-C5-NH2 (TFA)
BACK ORDERRS-Z401GEM -
Lenalidomide-C6-acid
BACK ORDERRS-L027064 -
Lenalidomide-d4
IN STOCKRS-L027058 -
Lenalidomide-PEG1-C2-acid
CUSTOM SYNTHESISRS-L027065 -
Lenalidomide-PEG2-C2-acid
CUSTOM SYNTHESISRS-L027066 -
Lenalidomide-PEG3-C2-acid
BACK ORDERRS-L027067 -
Lenalidomide-PEG4-C2-acid
BACK ORDERRS-L027068 -
Lenalidomide-PEG5-C2-acid
BACK ORDERRS-L027069 -
Lenalidomide-propargyl-C2-NH2 (hydrochloride)
BACK ORDERRS-L027070 -
Methyl 2-(azidomethyl)-3-nitrobenzoate
IN STOCKRS-Z401L52 -
Methyl 2-(bromomethyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]benzoate
IN STOCKRS-Z400BEG -
Methyl 2-(dibromomethyl)-6-nitrobenzoate
BACK ORDERRS-U082614 -
Methyl 2-methoxy-3-nitrobenzoate
IN STOCKRS-U082951 -
Methyl 2-methyl-4-nitrobenzoate
IN STOCKRS-C001085 -
Methyl 2-methyl-6-nitrobenzoate
IN STOCKRS-C001082 -
Methyl 3-(bromomethyl)-2-nitrobenzoate
CUSTOM SYNTHESISRS-P140022 -
Methyl 3-methyl-4-nitrobenzenecarboxylate
IN STOCKRS-Z401FZZ -
Methyl 3-Methyl-4-nitrobenzoate
IN STOCKRS-Z401FZY -
Methyl 3-methyl-5-nitrobenzoate
IN STOCKRS-U082751 -
Methyl 4-(bromomethyl)-3-nitrobenzoate
IN STOCKRS-P140054 -
methyl 5-amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoate
IN STOCKRS-L027098 -
Methyl 5-amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoate
IN STOCKRS-L027003 -
Methyl-2-(aminomethyl)-3-nitobenzoate
IN STOCKRS-U082195 -
N-Methyl analogue of Lenalidomide
IN STOCKRS-L027048 -
N-phthaloyl-L-glutamicacid
IN STOCKRS-I014140 -
Phthalyl-dl-glutamicacid
CUSTOM SYNTHESISRS-Z412OPU -
tert-butyl (2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)carbamate
IN STOCKRS-Z400BEH -
tert-Butyl (S)-(2,6-dioxopiperidin-3-yl)carbamate
CUSTOM SYNTHESISRS-P010200 -
214
IN STOCKRS-Z400I6F -
Lenalidomide Impurity 3
IN STOCKRS-L027005 -
Lenalidomide Impurity 5
IN STOCKRS-L027011 -
Lenalidomide Impurity 8 Monomer
IN STOCKRS-U003236 -
Lenalidomide Impurity 13
IN STOCKRS-L027049 -
Lenalidomide Impurity 14
IN STOCKRS-L027004 -
Lenalidomide Impurity 15
IN STOCKRS-L027021 -
Lenalidomide Impurity 15
IN STOCKRS-Z395VXC -
Lenalidomide Impurity 16
IN STOCKRS-L027006 -
Lenalidomide Impurity 17
IN STOCKRS-L027017 -
Lenalidomide Impurity 22
IN STOCKRS-L027041 -
Lenalidomide Impurity 40
CUSTOM SYNTHESISRS-L027051 -
Lenalidomide Impurity 43(Lenalidomide R-Isomer)
IN STOCKRS-L027043 -
Lenalidomide Impurity 47
IN STOCKRS-L027040 -
Lenalidomide Impurity 51
IN STOCKRS-L027024 -
Lenalidomide Impurity 52
CUSTOM SYNTHESISRS-L027025 -
Lenalidomide Impurity 62
IN STOCKRS-L027055 -
Lenalidomide Impurity 63
IN STOCKRS-U014093 -
Lenalidomide Impurity 64
IN STOCKRS-U003109 -
Lenalidomide Impurity 65
IN STOCKRS-L027019 -
Lenalidomide Impurity 66
IN STOCKRS-L027015 -
Lenalidomide Impurity 67
IN STOCKRS-L027037 -
Lenalidomide Impurity 68(Lenalidomide S-Isomer)
CUSTOM SYNTHESISRS-U009127 -
Lenalidomide Impurity 99
IN STOCKRS-L027056 -
Lenalidomide Impurity 107
IN STOCKRS-L027036 -
Lenalidomide Impurity 113
IN STOCKRS-L027020 -
Lenalidomide Impurity 114
IN STOCKRS-L027001 -
Lenalidomide Impurity 163
IN STOCKRS-L027072 -
Lenalidomide Impurity 164
IN STOCKRS-L027007 -
Lenalidomide Impurity 165
IN STOCKRS-L027008 -
Lenalidomide Impurity 166
IN STOCKRS-L027022 -
Lenalidomide Impurity 168
IN STOCKRS-L027042 -
Lenalidomide Impurity 169
IN STOCKRS-L027044 -
Lenalidomide Impurity 170
IN STOCKRS-L027054 -
Lenalidomide Impurity 190
IN STOCKRS-I014046 -
Lenalidomide Impurity 191
IN STOCKRS-L027002 -
Lenalidomide Impurity 192
IN STOCKRS-L027009 -
Lenalidomide Impurity 193
IN STOCKRS-L027012 -
Lenalidomide Impurity 194
IN STOCKRS-L027018 -
Lenalidomide Impurity 195
IN STOCKRS-L027023 -
Lenalidomide Impurity 196
IN STOCKRS-L027028 -
Lenalidomide Impurity 197
IN STOCKRS-L027029 -
Lenalidomide Impurity 198
IN STOCKRS-L027031 -
Lenalidomide Impurity 199
IN STOCKRS-L027035 -
Lenalidomide Impurity 200
IN STOCKRS-L027038 -
Lenalidomide Impurity 202
IN STOCKRS-L027050 -
Lenalidomide Impurity 203
IN STOCKRS-L027053 -
Lenalidomide Impurity 205
IN STOCKRS-L027073
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.










































































![Chemical structure of Methyl 2-(bromomethyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]benzoate](/structures/w4/RYYBLMZWEJYYGL-UHFFFAOYSA-N.webp?v=8)



























































